{"parse":{"title":"Fertility preservation","pageid":12977707,"revid":851291594,"text":{"*":"<div class=\"mw-parser-output\"><p><b>Fertility preservation</b> is the effort to help cancer patients retain their <a href=\"/wiki/Fertility\" title=\"Fertility\">fertility</a>, or ability to procreate. Research into how cancer affects reproductive health and preservation options are growing, sparked in part by the increase in the survival rate of cancer patients.\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Indications\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Indications</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-2\"><a href=\"#Cancer_treatment\"><span class=\"tocnumber\">1.1</span> <span class=\"toctext\">Cancer treatment</span></a></li>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#Aging\"><span class=\"tocnumber\">1.2</span> <span class=\"toctext\">Aging</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Methods\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Methods</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-5\"><a href=\"#Semen_cryopreservation\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\">Semen cryopreservation</span></a></li>\n<li class=\"toclevel-2 tocsection-6\"><a href=\"#Cryopreservation_of_ovarian_tissue_or_oocytes\"><span class=\"tocnumber\">2.2</span> <span class=\"toctext\">Cryopreservation of ovarian tissue or oocytes</span></a></li>\n<li class=\"toclevel-2 tocsection-7\"><a href=\"#Third-party_reproduction\"><span class=\"tocnumber\">2.3</span> <span class=\"toctext\">Third-party reproduction</span></a></li>\n<li class=\"toclevel-2 tocsection-8\"><a href=\"#Others\"><span class=\"tocnumber\">2.4</span> <span class=\"toctext\">Others</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-9\"><a href=\"#Adverse_effects\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Adverse effects</span></a></li>\n<li class=\"toclevel-1 tocsection-10\"><a href=\"#References\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-11\"><a href=\"#Further_reading\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Further reading</span></a></li>\n<li class=\"toclevel-1 tocsection-12\"><a href=\"#External_links\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Indications\">Indications</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Fertility_preservation&amp;action=edit&amp;section=1\" title=\"Edit section: Indications\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Fertility preservation procedures are indicated when it's predicted that there will be exposure to a cause of <a href=\"/wiki/Infertility\" title=\"Infertility\">infertility</a>, mainly <a href=\"/wiki/Cancer_treatment\" class=\"mw-redirect\" title=\"Cancer treatment\">cancer treatment</a>.\n</p>\n<h3><span class=\"mw-headline\" id=\"Cancer_treatment\">Cancer treatment</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Fertility_preservation&amp;action=edit&amp;section=2\" title=\"Edit section: Cancer treatment\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Chemotherapy and radiation treatments for cancer and other serious illnesses can affect reproductive health. The regimens that threaten ovarian and testicular function are mainly <a href=\"/wiki/Radiation_therapy\" title=\"Radiation therapy\">radiation therapy</a> to the pelvic area and some types of <a href=\"/wiki/Chemotherapy\" title=\"Chemotherapy\">chemotherapy</a>. Chemotherapies with high risk include <a href=\"/wiki/Procarbazine\" title=\"Procarbazine\">procarbazine</a> and <a href=\"/wiki/Alkylating_drug\" class=\"mw-redirect\" title=\"Alkylating drug\">alkylating drugs</a> such as <a href=\"/wiki/Cyclophosphamide\" title=\"Cyclophosphamide\">cyclophosphamide</a>, ifosfamide, busulfan, melphalan, chlorambucil and chlormethine.<sup id=\"cite_ref-Brydoy_1-0\" class=\"reference\"><a href=\"#cite_note-Brydoy-1\">&#91;1&#93;</a></sup> Drugs with medium risk include doxorubicin and platinum analogs such as cisplatin and carboplatin.<sup id=\"cite_ref-Brydoy_1-1\" class=\"reference\"><a href=\"#cite_note-Brydoy-1\">&#91;1&#93;</a></sup> On the other hand, therapies with low risk of gonadotoxicity include plant derivatives such as vincristine and vinblastine, antibiotics such as bleomycinand dactinomycin and antimetabolites such as methotrexate, mercaptopurine and 5-fluoruracil.<sup id=\"cite_ref-Brydoy_1-2\" class=\"reference\"><a href=\"#cite_note-Brydoy-1\">&#91;1&#93;</a></sup>\n</p><p>These regimens attack rapidly dividing cells in the body, including healthy cells like <a href=\"/wiki/Sperm\" title=\"Sperm\">sperm</a> and those belonging to the ovarian follicle (egg). Depending on the dose and duration of administration, these therapies can have varying effects on reproductive health. Surgery involving reproductive tissue affects reproductive function and fertility.\n</p><p>For many cancer patients, the decrease or loss of reproductive function is temporary; many men and women, however, do not regain fertility after cancer treatment. Patients undergoing serious radiation, chemotherapy, or surgery sometimes experience symptoms resembling <a href=\"/wiki/Menopause\" title=\"Menopause\">menopause</a> (in women) or andropause (in men), which indicate reproductive damage. In women, decreased <a href=\"/wiki/Estrogen\" title=\"Estrogen\">estrogen</a> levels as a result of ovarian deficiency lead to weakened bone, changes in temperature control, altered mood, and decreased sexual desire. Men with testicular insufficiency also experience similar symptoms.\n</p><p>A study indicated that fewer oocytes are recovered from cancer patients wanting to perform embryo preservation when compared with an age-matched control group, but the mean number of zygotes generated appears to be similar.<sup id=\"cite_ref-Klock_2-0\" class=\"reference\"><a href=\"#cite_note-Klock-2\">&#91;2&#93;</a></sup> The same study found that, of 65 patients referred to the program, 28% declined to undergo embryo, oocyte, or tissue cryopreservation. 9% were found not to be eligible for medical reasons. Of the remaining 41 patients, 85% chose to cryopreserve embryos, 10% chose to cryopreserve oocytes, and 5% chose to undergo ovarian tissue freezing.<sup id=\"cite_ref-Klock_2-1\" class=\"reference\"><a href=\"#cite_note-Klock-2\">&#91;2&#93;</a></sup> No serious clinical sequelae resulted from participation.<sup id=\"cite_ref-Klock_2-2\" class=\"reference\"><a href=\"#cite_note-Klock-2\">&#91;2&#93;</a></sup>\n</p><p>In women with cancer, a testing for the level of <a href=\"/wiki/Anti-M%C3%BCllerian_hormone\" title=\"Anti-M\u00fcllerian hormone\">anti-M\u00fcllerian hormone</a> (AMH) is useful in predicting the long-term post-chemotherapy loss of ovarian function, in turn predicting the need for fertility preservation strategies.<sup id=\"cite_ref-BroerBroekmans2014_3-0\" class=\"reference\"><a href=\"#cite_note-BroerBroekmans2014-3\">&#91;3&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Aging\">Aging</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Fertility_preservation&amp;action=edit&amp;section=3\" title=\"Edit section: Aging\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Fertility preservation, such as <a href=\"/wiki/Ovarian_tissue_cryopreservation\" title=\"Ovarian tissue cryopreservation\">ovarian tissue</a> or <a href=\"/wiki/Oocyte_cryopreservation\" title=\"Oocyte cryopreservation\">oocyte cryopreservation</a>, may also be used to prevent infertility, as well as <a href=\"/wiki/Birth_defect\" title=\"Birth defect\">birth defects</a>, associated with <a href=\"/wiki/Advanced_maternal_age\" title=\"Advanced maternal age\">advanced maternal age</a>.\n</p>\n<h2><span class=\"mw-headline\" id=\"Methods\">Methods</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Fertility_preservation&amp;action=edit&amp;section=4\" title=\"Edit section: Methods\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The main methods of fertility preservation are ovarian protection by <a href=\"/wiki/Gonadotropin-releasing_hormone_agonist\" title=\"Gonadotropin-releasing hormone agonist\">GnRH agonists</a>, <a href=\"/wiki/Cryopreservation\" title=\"Cryopreservation\">cryopreservation</a> of ovarian tissue, eggs or sperm, or of embryos after in vitro fertilization.<sup id=\"cite_ref-Cruz_4-0\" class=\"reference\"><a href=\"#cite_note-Cruz-4\">&#91;4&#93;</a></sup> The patient may also choose to use egg or sperm from a donor by <a href=\"/wiki/Third_party_reproduction\" class=\"mw-redirect\" title=\"Third party reproduction\">third party reproduction</a> rather than having biological children.\n</p>\n<h3><span class=\"mw-headline\" id=\"Semen_cryopreservation\">Semen cryopreservation</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Fertility_preservation&amp;action=edit&amp;section=5\" title=\"Edit section: Semen cryopreservation\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Further information: <a href=\"/wiki/Semen_cryopreservation\" title=\"Semen cryopreservation\">Semen cryopreservation</a></div>\n<p>Men hoping to preserve their fertility before undergoing treatment for cancer or another fertility-threatening disease can cryopreserve, or freeze, their sperm, which can be obtained through <a href=\"/wiki/Masturbation\" title=\"Masturbation\">masturbation</a> in post-pubescent boys and men. This is the most established fertility preservation method for males. For pre-pubescent boys, sperm can be obtained through testicular aspiration or electrostimulation and then stored for future use. Researchers are also looking at methods for cryopreserving testicular tissue samples so that they can be re-implanted into the body after treatment.\n</p>\n<h3><span class=\"mw-headline\" id=\"Cryopreservation_of_ovarian_tissue_or_oocytes\">Cryopreservation of ovarian tissue or oocytes</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Fertility_preservation&amp;action=edit&amp;section=6\" title=\"Edit section: Cryopreservation of ovarian tissue or oocytes\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Further information: <a href=\"/wiki/Oocyte_cryopreservation\" title=\"Oocyte cryopreservation\">Oocyte cryopreservation</a> and <a href=\"/wiki/Ovarian_tissue_cryopreservation\" title=\"Ovarian tissue cryopreservation\">Ovarian tissue cryopreservation</a></div>\n<p>Some female patients choose to have mature eggs extracted and fertilized outside of the body with sperm from a partner or donor. The resulting embryo is then frozen until the woman is in remission from disease. When the woman is ready to initiate pregnancy, the embryo is thawed and implanted into the uterus for maturation and birth. While this option is the most common fertility preservation method in women, it is not available to pre-pubescent girls, who do not have mature eggs that can be fertilized.  Women who do not have a partner will need to use donor sperm. Additionally, because this procedure requires a two-week period of hormonal stimulation to encourage egg maturation, it is not optimal for female patients who are diagnosed with hormone-sensitive cancers (such as <a href=\"/wiki/Breast_cancer\" title=\"Breast cancer\">breast cancer</a>, <a href=\"/wiki/Ovarian_cancer\" title=\"Ovarian cancer\">ovarian cancer</a>, etc.) or those who cannot delay cancer treatment. Alternative methods of hormonal stimulation using letrozole or tamoxifen may be used for women with hormone-sensitive cancers.\n</p><p>Strips of cortical ovarian tissue can also be cryopreserved, but it must be re-implanted into the body to allow the encapsulated immature follicles to complete their maturation. Furthermore, ovarian tissue is fragile under hard freezing conditions and putting it back into the body carries the risk of re-introducing cancerous cells. <a href=\"/wiki/In_vitro_maturation\" title=\"In vitro maturation\">In vitro maturation</a> has been achieved experimentally, but the technique is not yet clinically available.<sup id=\"cite_ref-McLaughlinAlbertini2018_5-0\" class=\"reference\"><a href=\"#cite_note-McLaughlinAlbertini2018-5\">&#91;5&#93;</a></sup> With this technique, cryopreserved ovarian tissue could possibly be used to make oocytes that can directly undergo <a href=\"/wiki/In_vitro_fertilization\" class=\"mw-redirect\" title=\"In vitro fertilization\">in vitro fertilization</a>.<sup id=\"cite_ref-McLaughlinAlbertini2018_5-1\" class=\"reference\"><a href=\"#cite_note-McLaughlinAlbertini2018-5\">&#91;5&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Third-party_reproduction\">Third-party reproduction</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Fertility_preservation&amp;action=edit&amp;section=7\" title=\"Edit section: Third-party reproduction\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Many patients diagnosed with a malignancy or another disease requiring treatment that may impair their fertility consider alternatives to bearing biological children, such as <a href=\"/wiki/Assisted_reproductive_technology\" title=\"Assisted reproductive technology\">assisted reproductive technology</a> (ART) using in vitro fertilization (IVF) with donor eggs or donor sperm. The resulting embryo can be implanted into the woman's uterus after her <a href=\"/wiki/Endometrium\" title=\"Endometrium\">endometrium</a> (the lining of the uterus) is stimulated with hormones to prepare for the development of the embryo.\n</p>\n<h3><span class=\"mw-headline\" id=\"Others\">Others</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Fertility_preservation&amp;action=edit&amp;section=8\" title=\"Edit section: Others\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>In women requiring local pelvic <a href=\"/wiki/Radiation_therapy\" title=\"Radiation therapy\">radiation therapy</a> may benefit from surgical transposition of the ovaries to a site remote from maximal radiation exposure.<sup id=\"cite_ref-ASRM2013_6-0\" class=\"reference\"><a href=\"#cite_note-ASRM2013-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup>\n</p><p>The use of <a href=\"/wiki/GnRH_agonists\" class=\"mw-redirect\" title=\"GnRH agonists\">GnRH agonists</a> for ovarian protection during chemotherapy is suggested to benefit the ability to <a href=\"/wiki/Ovulation\" title=\"Ovulation\">ovulate</a>, but benefits in terms of e.g. pregnancy rate are lacking.<sup id=\"cite_ref-ASRM2013_6-1\" class=\"reference\"><a href=\"#cite_note-ASRM2013-6\">&#91;6&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Adverse_effects\">Adverse effects</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Fertility_preservation&amp;action=edit&amp;section=9\" title=\"Edit section: Adverse effects\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Compared with the general population, people with <a href=\"/wiki/Cancer\" title=\"Cancer\">cancer</a> have a higher risk of arterial thrombotic events such as <a href=\"/wiki/Stroke\" title=\"Stroke\">stroke</a>, <a href=\"/wiki/Myocardial_infarction\" title=\"Myocardial infarction\">myocardial infarction</a> and peripheral <a href=\"/wiki/Arterial_embolism\" title=\"Arterial embolism\">arterial embolism</a>. This risk has a potential to be further increased in women undergoing <a href=\"/wiki/Controlled_ovarian_hyperstimulation\" title=\"Controlled ovarian hyperstimulation\">controlled ovarian hyperstimulation</a> for fertility preservation, but is usually only associated with cases of <a href=\"/wiki/Ovarian_hyperstimulation_syndrome\" title=\"Ovarian hyperstimulation syndrome\">ovarian hyperstimulation syndrome</a> (OHSS). On the other hand, <a href=\"/wiki/Venous_thromboembolism\" class=\"mw-redirect\" title=\"Venous thromboembolism\">venous thromboembolism</a> rarely occurs unless a pregnancy is achieved, and is therefore usually not particularly relevant in the stage of <a href=\"/wiki/Oocyte_retrieval\" class=\"mw-redirect\" title=\"Oocyte retrieval\">oocyte retrieval</a>.<sup id=\"cite_ref-SomiglianaPeccatori2014_8-0\" class=\"reference\"><a href=\"#cite_note-SomiglianaPeccatori2014-8\">&#91;8&#93;</a></sup> Therefore, the recommended <a href=\"/wiki/Controlled_ovarian_hyperstimulation\" title=\"Controlled ovarian hyperstimulation\">controlled ovarian hyperstimulation</a> protocol for in women with cancer is an <a href=\"/wiki/Antagonist_protocol\" class=\"mw-redirect\" title=\"Antagonist protocol\">antagonist protocol</a> using a <a href=\"/wiki/GnRH_agonist\" class=\"mw-redirect\" title=\"GnRH agonist\">GnRH agonist</a> for <a href=\"/wiki/Final_maturation_induction\" title=\"Final maturation induction\">final maturation induction</a>, in order to decrease the risk of OHSS.<sup id=\"cite_ref-SomiglianaPeccatori2014_8-1\" class=\"reference\"><a href=\"#cite_note-SomiglianaPeccatori2014-8\">&#91;8&#93;</a></sup> When used in conjunction with oocyte or embryo cryopreservation, using GnRH agonist rather than hCG for final maturation induction has no evidence of a difference in <a href=\"/wiki/Live_birth_rate\" class=\"mw-redirect\" title=\"Live birth rate\">live birth rate</a> (in contrast to fresh cycles where usage of GnRH agonist has a lower live birth rate).<sup id=\"cite_ref-YoussefVan_der_Veen2014_9-0\" class=\"reference\"><a href=\"#cite_note-YoussefVan_der_Veen2014-9\">&#91;9&#93;</a></sup> <a href=\"/wiki/Anticoagulant\" title=\"Anticoagulant\">Anticoagulant</a> prophylaxis is recommended to be administered only to selected subgroups of women such as those with other risk factors of <a href=\"/wiki/Hypercoagulability\" class=\"mw-redirect\" title=\"Hypercoagulability\">hypercoagulability</a> or those who do develop early OHSS.<sup id=\"cite_ref-SomiglianaPeccatori2014_8-2\" class=\"reference\"><a href=\"#cite_note-SomiglianaPeccatori2014-8\">&#91;8&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Fertility_preservation&amp;action=edit&amp;section=10\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap\"><ol class=\"references\">\n<li id=\"cite_note-Brydoy-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Brydoy_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Brydoy_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Brydoy_1-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bryd\u00f8y M, Foss\u00e5 SD, Dahl O, Bj\u00f8ro T (2007). <a rel=\"nofollow\" class=\"external text\" href=\"http://informahealthcare.com/doi/pdf/10.1080/02841860601166958\">\"Gonadal dysfunction and fertility problems in cancer survivors\"</a>. <i>Acta Oncol</i>. <b>46</b> (4): 480\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1080/02841860601166958\">10.1080/02841860601166958</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17497315\">17497315</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Acta+Oncol&amp;rft.atitle=Gonadal+dysfunction+and+fertility+problems+in+cancer+survivors&amp;rft.volume=46&amp;rft.issue=4&amp;rft.pages=480-9&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1080%2F02841860601166958&amp;rft_id=info%3Apmid%2F17497315&amp;rft.aulast=Bryd%C3%B8y&amp;rft.aufirst=M&amp;rft.au=Foss%C3%A5%2C+SD&amp;rft.au=Dahl%2C+O&amp;rft.au=Bj%C3%B8ro%2C+T&amp;rft_id=http%3A%2F%2Finformahealthcare.com%2Fdoi%2Fpdf%2F10.1080%2F02841860601166958&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AFertility+preservation\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Klock-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Klock_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Klock_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Klock_2-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Klock, S.; Zhang, J.; Kazer, R. (2010). \"Fertility preservation for female cancer patients: early clinical experience\". <i>Fertility and Sterility</i>. <b>94</b> (1): 149\u2013155. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.fertnstert.2009.03.028\">10.1016/j.fertnstert.2009.03.028</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19406395\">19406395</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Fertility+and+Sterility&amp;rft.atitle=Fertility+preservation+for+female+cancer+patients%3A+early+clinical+experience&amp;rft.volume=94&amp;rft.issue=1&amp;rft.pages=149-155&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1016%2Fj.fertnstert.2009.03.028&amp;rft_id=info%3Apmid%2F19406395&amp;rft.aulast=Klock&amp;rft.aufirst=S.&amp;rft.au=Zhang%2C+J.&amp;rft.au=Kazer%2C+R.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AFertility+preservation\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-BroerBroekmans2014-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-BroerBroekmans2014_3-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Broer, S. L.; Broekmans, F. J. M.; Laven, J. S. E.; Fauser, B. C. J. M. (2014). \"Anti-Mullerian hormone: ovarian reserve testing and its potential clinical implications\". <i>Human Reproduction Update</i>. <b>20</b> (5): 688\u2013701. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/humupd/dmu020\">10.1093/humupd/dmu020</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1355-4786\">1355-4786</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24821925\">24821925</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Human+Reproduction+Update&amp;rft.atitle=Anti-Mullerian+hormone%3A+ovarian+reserve+testing+and+its+potential+clinical+implications&amp;rft.volume=20&amp;rft.issue=5&amp;rft.pages=688-701&amp;rft.date=2014&amp;rft.issn=1355-4786&amp;rft_id=info%3Apmid%2F24821925&amp;rft_id=info%3Adoi%2F10.1093%2Fhumupd%2Fdmu020&amp;rft.aulast=Broer&amp;rft.aufirst=S.+L.&amp;rft.au=Broekmans%2C+F.+J.+M.&amp;rft.au=Laven%2C+J.+S.+E.&amp;rft.au=Fauser%2C+B.+C.+J.+M.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AFertility+preservation\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Cruz-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Cruz_4-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Cruz, M.; Prestes, J.; Gimenes, D.; Fanelli, M. (2010). \"Fertility preservation in women with breast cancer undergoing adjuvant chemotherapy: a systematic review\". <i>Fertility and Sterility</i>. <b>94</b> (1): 138\u2013143. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.fertnstert.2009.02.055\">10.1016/j.fertnstert.2009.02.055</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19339000\">19339000</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Fertility+and+Sterility&amp;rft.atitle=Fertility+preservation+in+women+with+breast+cancer+undergoing+adjuvant+chemotherapy%3A+a+systematic+review&amp;rft.volume=94&amp;rft.issue=1&amp;rft.pages=138-143&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1016%2Fj.fertnstert.2009.02.055&amp;rft_id=info%3Apmid%2F19339000&amp;rft.aulast=Cruz&amp;rft.aufirst=M.&amp;rft.au=Prestes%2C+J.&amp;rft.au=Gimenes%2C+D.&amp;rft.au=Fanelli%2C+M.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AFertility+preservation\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-McLaughlinAlbertini2018-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-McLaughlinAlbertini2018_5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-McLaughlinAlbertini2018_5-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">\n<ul><li><cite class=\"citation journal\">McLaughlin, M; Albertini, D F; Wallace, W H B; Anderson, R A; Telfer, E E (2018). \"Metaphase II oocytes from human unilaminar follicles grown in a multi-step culture system\". <i>MHR: Basic science of reproductive medicine</i>. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/molehr/gay002\">10.1093/molehr/gay002</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1360-9947\">1360-9947</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=MHR%3A+Basic+science+of+reproductive+medicine&amp;rft.atitle=Metaphase+II+oocytes+from+human+unilaminar+follicles+grown+in+a+multi-step+culture+system&amp;rft.date=2018&amp;rft_id=info%3Adoi%2F10.1093%2Fmolehr%2Fgay002&amp;rft.issn=1360-9947&amp;rft.aulast=McLaughlin&amp;rft.aufirst=M&amp;rft.au=Albertini%2C+D+F&amp;rft.au=Wallace%2C+W+H+B&amp;rft.au=Anderson%2C+R+A&amp;rft.au=Telfer%2C+E+E&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AFertility+preservation\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li>Further comments in <a href=\"/wiki/BBC_news\" class=\"mw-redirect\" title=\"BBC news\">BBC news</a> article: <cite class=\"citation web\">James Gallagher (2018-02-09). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.bbc.com/news/health-42976858\">\"First human eggs grown in laboratory\"</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=First+human+eggs+grown+in+laboratory&amp;rft.date=2018-02-09&amp;rft.au=James+Gallagher&amp;rft_id=https%3A%2F%2Fwww.bbc.com%2Fnews%2Fhealth-42976858&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AFertility+preservation\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li></ul>\n</span></li>\n<li id=\"cite_note-ASRM2013-6\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ASRM2013_6-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ASRM2013_6-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">American Society for Reproductive Medicine: <cite class=\"citation journal\">\"Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: A committee opinion\". <i>Fertility and Sterility</i>. <b>100</b>: 1214\u20131223. 2013. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.fertnstert.2013.08.012\">10.1016/j.fertnstert.2013.08.012</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Fertility+and+Sterility&amp;rft.atitle=Fertility+preservation+in+patients+undergoing+gonadotoxic+therapy+or+gonadectomy%3A+A+committee+opinion&amp;rft.volume=100&amp;rft.pages=1214-1223&amp;rft.date=2013&amp;rft_id=info%3Adoi%2F10.1016%2Fj.fertnstert.2013.08.012&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AFertility+preservation\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\">Sabine Irtan, Daniel Orbach, Sylvie Helfre, Sabine Sarnacki: <i>Ovarian transposition in prepubescent and adolescent girls with cancer.</i> Lancet Oncol. 14 (2013), 601-8, <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FS1470-2045%2813%2970288-2\">10.1016/S1470-2045(13)70288-2</a>.</span>\n</li>\n<li id=\"cite_note-SomiglianaPeccatori2014-8\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-SomiglianaPeccatori2014_8-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-SomiglianaPeccatori2014_8-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-SomiglianaPeccatori2014_8-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Somigliana, E.; Peccatori, F. A.; Filippi, F.; Martinelli, F.; Raspagliesi, F.; Martinelli, I. (2014). \"Risk of thrombosis in women with malignancies undergoing ovarian stimulation for fertility preservation\". <i>Human Reproduction Update</i>. <b>20</b> (6): 944\u2013951. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/humupd/dmu035\">10.1093/humupd/dmu035</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1355-4786\">1355-4786</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25013217\">25013217</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Human+Reproduction+Update&amp;rft.atitle=Risk+of+thrombosis+in+women+with+malignancies+undergoing+ovarian+stimulation+for+fertility+preservation&amp;rft.volume=20&amp;rft.issue=6&amp;rft.pages=944-951&amp;rft.date=2014&amp;rft.issn=1355-4786&amp;rft_id=info%3Apmid%2F25013217&amp;rft_id=info%3Adoi%2F10.1093%2Fhumupd%2Fdmu035&amp;rft.aulast=Somigliana&amp;rft.aufirst=E.&amp;rft.au=Peccatori%2C+F.+A.&amp;rft.au=Filippi%2C+F.&amp;rft.au=Martinelli%2C+F.&amp;rft.au=Raspagliesi%2C+F.&amp;rft.au=Martinelli%2C+I.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AFertility+preservation\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-YoussefVan_der_Veen2014-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-YoussefVan_der_Veen2014_9-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Youssef, Mohamed AFM; Van der Veen, Fulco; Al-Inany, Hesham G; Mochtar, Monique H; Griesinger, Georg; Nagi Mohesen, Mohamed; Aboulfoutouh, Ismail; van Wely, Madelon; Youssef, Mohamed AFM (2014). \"Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology\". <i>Reviews</i> (10): CD008046. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/14651858.CD008046.pub4\">10.1002/14651858.CD008046.pub4</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25358904\">25358904</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reviews&amp;rft.atitle=Gonadotropin-releasing+hormone+agonist+versus+HCG+for+oocyte+triggering+in+antagonist-assisted+reproductive+technology&amp;rft.issue=10&amp;rft.pages=CD008046&amp;rft.date=2014&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD008046.pub4&amp;rft_id=info%3Apmid%2F25358904&amp;rft.aulast=Youssef&amp;rft.aufirst=Mohamed+AFM&amp;rft.au=Van+der+Veen%2C+Fulco&amp;rft.au=Al-Inany%2C+Hesham+G&amp;rft.au=Mochtar%2C+Monique+H&amp;rft.au=Griesinger%2C+Georg&amp;rft.au=Nagi+Mohesen%2C+Mohamed&amp;rft.au=Aboulfoutouh%2C+Ismail&amp;rft.au=van+Wely%2C+Madelon&amp;rft.au=Youssef%2C+Mohamed+AFM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AFertility+preservation\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div></div>\n<h2><span class=\"mw-headline\" id=\"Further_reading\">Further reading</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Fertility_preservation&amp;action=edit&amp;section=11\" title=\"Edit section: Further reading\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li>American Society for Reproductive Medicine: <cite class=\"citation journal\">\"Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: A committee opinion\". <i>Fertility and Sterility</i>. <b>100</b>: 1214\u20131223. 2013. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.fertnstert.2013.08.012\">10.1016/j.fertnstert.2013.08.012</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Fertility+and+Sterility&amp;rft.atitle=Fertility+preservation+in+patients+undergoing+gonadotoxic+therapy+or+gonadectomy%3A+A+committee+opinion&amp;rft.volume=100&amp;rft.pages=1214-1223&amp;rft.date=2013&amp;rft_id=info%3Adoi%2F10.1016%2Fj.fertnstert.2013.08.012&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AFertility+preservation\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation web\">Mayo Foundation for Medical Education and Research (2007). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.mayoclinic.com/health/cancer-treatment/SA00070\">\"Cancer treatment for men: Possible sexual side effects\"</a>. MayoClinic.com.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Cancer+treatment+for+men%3A+Possible+sexual+side+effects.&amp;rft.pub=MayoClinic.com&amp;rft.date=2007&amp;rft.au=Mayo+Foundation+for+Medical+Education+and+Research&amp;rft_id=http%3A%2F%2Fwww.mayoclinic.com%2Fhealth%2Fcancer-treatment%2FSA00070&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AFertility+preservation\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation journal\">Magelssen, H.; M. Brydoy, S.D. Fossa (2006). \"The effects of cancer and cancer treatments on male reproductive function\". <i>Nature Clinical Practice Urology</i> (6 ed.). <b>3</b> (6): 312\u2013322. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/ncpuro0508\">10.1038/ncpuro0508</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16763643\">16763643</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Clinical+Practice+Urology&amp;rft.atitle=The+effects+of+cancer+and+cancer+treatments+on+male+reproductive+function&amp;rft.volume=3&amp;rft.issue=6&amp;rft.pages=312-322&amp;rft.date=2006&amp;rft_id=info%3Adoi%2F10.1038%2Fncpuro0508&amp;rft_id=info%3Apmid%2F16763643&amp;rft.aulast=Magelssen&amp;rft.aufirst=H.&amp;rft.au=M.+Brydoy%2C+S.D.+Fossa&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AFertility+preservation\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation journal\">von Wolff Michael, Montag Markus, Dittrich Ralf, Denschlag Dominik, Nawroth Frank, Lawrenz Barbara (2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3133651\">\"Fertility preservation in women - a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT\"</a>. <i>Archives of Gynecology and Obstetrics</i>. <b>284</b>: 427\u2013435. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s00404-011-1874-1\">10.1007/s00404-011-1874-1</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3133651\">3133651</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+Gynecology+and+Obstetrics&amp;rft.atitle=Fertility+preservation+in+women+-+a+practical+guide+to+preservation+techniques+and+therapeutic+strategies+in+breast+cancer%2C+Hodgkin%27s+lymphoma+and+borderline+ovarian+tumours+by+the+fertility+preservation+network+FertiPROTEKT.&amp;rft.volume=284&amp;rft.pages=427-435&amp;rft.date=2011&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3133651&amp;rft_id=info%3Adoi%2F10.1007%2Fs00404-011-1874-1&amp;rft.au=von+Wolff+Michael%2C+Montag+Markus%2C+Dittrich+Ralf%2C+Denschlag+Dominik%2C+Nawroth+Frank%2C+Lawrenz+Barbara&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3133651&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AFertility+preservation\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><span class=\"citation-comment\" style=\"display:none; color:#33aa33; margin-left:0.3em\">CS1 maint: Multiple names: authors list (<a href=\"/wiki/Category:CS1_maint:_Multiple_names:_authors_list\" title=\"Category:CS1 maint: Multiple names: authors list\">link</a>) </span></li>\n<li>Clarisa Gracia, Teresa K Woodruff: <i>Oncofertility Medical Practice: Clinical Issues and Implementation.</i> Springer, 2012, <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/1-441-99425-4\" title=\"Special:BookSources/1-441-99425-4\">1-441-99425-4</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Fertility_preservation&amp;action=edit&amp;section=12\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20120904082833/http://reprotech.com/cryostorage/fertility-preservation/about-fertility-preservation.html\">Fertility Preservation, ReproTech website</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://reprotech.com/cryostorage/for-men/semen-storage.html\">Semen Storage through Cryopreservation</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://reprotech.com/cryostorage/for-women/embryo-storage.html\">Embryo Storage through Cryopreservation</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://reprotech.com/cryostorage/for-women/oocyte-storage.html\">Oocyte Cryostorage</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://reprotech.com/cryostorage/for-women/ovarian-tissue.html\">Ovarian Tissue Cryostorage Services</a></li>\n<li><a rel=\"nofollow\" class=\"external free\" href=\"http://oncofertility.northwestern.edu\">http://oncofertility.northwestern.edu</a></li>\n<li><a rel=\"nofollow\" class=\"external free\" href=\"http://savemyfertility.org/\">http://savemyfertility.org/</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.fertiprotekt.com/index.php?PHPSESSID=01f23it0gbb2li1grf5vo8g5u6&amp;lang=uk\">FertiPROTEKT</a>, network for fertility protection of German-speaking countries</li></ul>\n\n<!-- \nNewPP limit report\nParsed by mw1284\nCached time: 20180910033727\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.232 seconds\nReal time usage: 0.279 seconds\nPreprocessor visited node count: 1025/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 29551/2097152 bytes\nTemplate argument size: 728/2097152 bytes\nHighest expansion depth: 15/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 15046/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.112/10.000 seconds\nLua memory usage: 2.94 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  224.798      1 -total\n 60.68%  136.413      1 Template:Reflist\n 50.09%  112.607     11 Template:Cite_journal\n 13.62%   30.614      2 Template:See\n 11.56%   25.989      1 Template:ISBN\n  5.59%   12.567      2 Template:Cite_web\n  4.97%   11.183      1 Template:Catalog_lookup_link\n  4.19%    9.409      1 Template:DOI\n  2.48%    5.578      1 Template:Error-small\n  1.92%    4.321      3 Template:Yesno-no\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:12977707-0!canonical and timestamp 20180910033727 and revision id 851291594\n -->\n</div>"},"langlinks":[{"lang":"az","url":"https://az.wikipedia.org/wiki/Fertillik_Qorunmas%C4%B1","langname":"Azerbaijani","autonym":"az\u0259rbaycanca","*":"Fertillik Qorunmas\u0131"},{"lang":"ja","url":"https://ja.wikipedia.org/wiki/%E5%A6%8A%E5%AD%95%E6%80%A7%E6%B8%A9%E5%AD%98%E7%99%82%E6%B3%95","langname":"Japanese","autonym":"\u65e5\u672c\u8a9e","*":"\u598a\u5b55\u6027\u6e29\u5b58\u7642\u6cd5"}],"categories":[{"sortkey":"","hidden":"","*":"CS1_maint:_Multiple_names:_authors_list"},{"sortkey":"","*":"Oncology"},{"sortkey":"","*":"Fertility_medicine"}],"links":[{"ns":0,"exists":"","*":"Advanced maternal age"},{"ns":0,"exists":"","*":"Alkylating drug"},{"ns":0,"exists":"","*":"Antagonist protocol"},{"ns":0,"exists":"","*":"Anti-M\u00fcllerian hormone"},{"ns":0,"exists":"","*":"Anticoagulant"},{"ns":0,"exists":"","*":"Arterial embolism"},{"ns":0,"exists":"","*":"Assisted reproductive technology"},{"ns":0,"exists":"","*":"BBC news"},{"ns":0,"exists":"","*":"Birth defect"},{"ns":0,"exists":"","*":"Breast cancer"},{"ns":0,"exists":"","*":"Cancer"},{"ns":0,"exists":"","*":"Cancer treatment"},{"ns":0,"exists":"","*":"Chemotherapy"},{"ns":0,"exists":"","*":"Controlled ovarian hyperstimulation"},{"ns":0,"exists":"","*":"Cryopreservation"},{"ns":0,"exists":"","*":"Cyclophosphamide"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Endometrium"},{"ns":0,"exists":"","*":"Estrogen"},{"ns":0,"exists":"","*":"Fertility"},{"ns":0,"exists":"","*":"Final maturation induction"},{"ns":0,"exists":"","*":"GnRH agonist"},{"ns":0,"exists":"","*":"GnRH agonists"},{"ns":0,"exists":"","*":"Gonadotropin-releasing hormone agonist"},{"ns":0,"exists":"","*":"Hypercoagulability"},{"ns":0,"exists":"","*":"In vitro fertilization"},{"ns":0,"exists":"","*":"In vitro maturation"},{"ns":0,"exists":"","*":"Infertility"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"International Standard Serial Number"},{"ns":0,"exists":"","*":"Live birth rate"},{"ns":0,"exists":"","*":"Masturbation"},{"ns":0,"exists":"","*":"Menopause"},{"ns":0,"exists":"","*":"Myocardial infarction"},{"ns":0,"exists":"","*":"Oocyte cryopreservation"},{"ns":0,"exists":"","*":"Oocyte retrieval"},{"ns":0,"exists":"","*":"Ovarian cancer"},{"ns":0,"exists":"","*":"Ovarian hyperstimulation syndrome"},{"ns":0,"exists":"","*":"Ovarian tissue cryopreservation"},{"ns":0,"exists":"","*":"Ovulation"},{"ns":0,"exists":"","*":"Procarbazine"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Radiation therapy"},{"ns":0,"exists":"","*":"Semen cryopreservation"},{"ns":0,"exists":"","*":"Sperm"},{"ns":0,"exists":"","*":"Stroke"},{"ns":0,"exists":"","*":"Third party reproduction"},{"ns":0,"exists":"","*":"Venous thromboembolism"},{"ns":14,"exists":"","*":"Category:CS1 maint: Multiple names: authors list"}],"templates":[{"ns":10,"exists":"","*":"Template:See"},{"ns":10,"exists":"","*":"Template:Further"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:DOI"},{"ns":10,"exists":"","*":"Template:Doi"},{"ns":10,"exists":"","*":"Template:Hide in print"},{"ns":10,"exists":"","*":"Template:Str left"},{"ns":10,"exists":"","*":"Template:Only in print"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:ISBN"},{"ns":10,"exists":"","*":"Template:Catalog lookup link"},{"ns":10,"exists":"","*":"Template:Trim"},{"ns":10,"exists":"","*":"Template:Yesno-no"},{"ns":10,"exists":"","*":"Template:Yesno"},{"ns":10,"exists":"","*":"Template:Error-small"},{"ns":10,"exists":"","*":"Template:Tl"},{"ns":828,"exists":"","*":"Module:Labelled list hatnote"},{"ns":828,"exists":"","*":"Module:Hatnote"},{"ns":828,"exists":"","*":"Module:Hatnote list"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Check isxn"},{"ns":828,"exists":"","*":"Module:Error"}],"images":["Lock-green.svg"],"externallinks":["http://informahealthcare.com/doi/pdf/10.1080/02841860601166958","//doi.org/10.1080/02841860601166958","//www.ncbi.nlm.nih.gov/pubmed/17497315","//doi.org/10.1016/j.fertnstert.2009.03.028","//www.ncbi.nlm.nih.gov/pubmed/19406395","//doi.org/10.1093/humupd/dmu020","//www.worldcat.org/issn/1355-4786","//www.ncbi.nlm.nih.gov/pubmed/24821925","//doi.org/10.1016/j.fertnstert.2009.02.055","//www.ncbi.nlm.nih.gov/pubmed/19339000","//doi.org/10.1093/molehr/gay002","//www.worldcat.org/issn/1360-9947","https://www.bbc.com/news/health-42976858","//doi.org/10.1016/j.fertnstert.2013.08.012","https://doi.org/10.1016%2FS1470-2045(13)70288-2","//doi.org/10.1093/humupd/dmu035","//www.ncbi.nlm.nih.gov/pubmed/25013217","//doi.org/10.1002/14651858.CD008046.pub4","//www.ncbi.nlm.nih.gov/pubmed/25358904","http://www.mayoclinic.com/health/cancer-treatment/SA00070","//doi.org/10.1038/ncpuro0508","//www.ncbi.nlm.nih.gov/pubmed/16763643","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3133651","//doi.org/10.1007/s00404-011-1874-1","https://web.archive.org/web/20120904082833/http://reprotech.com/cryostorage/fertility-preservation/about-fertility-preservation.html","http://reprotech.com/cryostorage/for-men/semen-storage.html","http://reprotech.com/cryostorage/for-women/embryo-storage.html","http://reprotech.com/cryostorage/for-women/oocyte-storage.html","http://reprotech.com/cryostorage/for-women/ovarian-tissue.html","http://www.fertiprotekt.com/index.php?PHPSESSID=01f23it0gbb2li1grf5vo8g5u6&lang=uk","http://oncofertility.northwestern.edu","http://savemyfertility.org/"],"sections":[{"toclevel":1,"level":"2","line":"Indications","number":"1","index":"1","fromtitle":"Fertility_preservation","byteoffset":285,"anchor":"Indications"},{"toclevel":2,"level":"3","line":"Cancer treatment","number":"1.1","index":"2","fromtitle":"Fertility_preservation","byteoffset":458,"anchor":"Cancer_treatment"},{"toclevel":2,"level":"3","line":"Aging","number":"1.2","index":"3","fromtitle":"Fertility_preservation","byteoffset":4212,"anchor":"Aging"},{"toclevel":1,"level":"2","line":"Methods","number":"2","index":"4","fromtitle":"Fertility_preservation","byteoffset":4454,"anchor":"Methods"},{"toclevel":2,"level":"3","line":"Semen cryopreservation","number":"2.1","index":"5","fromtitle":"Fertility_preservation","byteoffset":5244,"anchor":"Semen_cryopreservation"},{"toclevel":2,"level":"3","line":"Cryopreservation of ovarian tissue or oocytes","number":"2.2","index":"6","fromtitle":"Fertility_preservation","byteoffset":5894,"anchor":"Cryopreservation_of_ovarian_tissue_or_oocytes"},{"toclevel":2,"level":"3","line":"Third-party reproduction","number":"2.3","index":"7","fromtitle":"Fertility_preservation","byteoffset":8207,"anchor":"Third-party_reproduction"},{"toclevel":2,"level":"3","line":"Others","number":"2.4","index":"8","fromtitle":"Fertility_preservation","byteoffset":8714,"anchor":"Others"},{"toclevel":1,"level":"2","line":"Adverse effects","number":"3","index":"9","fromtitle":"Fertility_preservation","byteoffset":9655,"anchor":"Adverse_effects"},{"toclevel":1,"level":"2","line":"References","number":"4","index":"10","fromtitle":"Fertility_preservation","byteoffset":12087,"anchor":"References"},{"toclevel":1,"level":"2","line":"Further reading","number":"5","index":"11","fromtitle":"Fertility_preservation","byteoffset":12115,"anchor":"Further_reading"},{"toclevel":1,"level":"2","line":"External links","number":"6","index":"12","fromtitle":"Fertility_preservation","byteoffset":13715,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Fertility preservation","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q5445580"}]}}